athira pharma stock forecast
Based on 5 Wall Street analysts offering 12 month price targets for Athira Pharma in the last 3 months. ATHA one year forecast.
Athira Pharma Inc Atha Stock Price Quote News Stock Analysis
The forecasts range from a low of 350.
. Athira Pharma Inc ATHA Stock Forecast By Analysts Moderate Buy Analysts Recommendations for Athira Pharma Inc ATHA is based on 10 Institutional Analyst Ratings. ATHA IEX Real-Time Price USD 293. Is 337 for 2023 Jul.
Athira Pharma Inc. Analyst Price Target on ATHA. Find out the current price target and stock forecast for Athira Pharma ATHA.
Athira Pharma Inc. Signals Forecast. Athira Pharma Inc stock price forecast for further price development up to 578 time horizon.
That Athira Pharmas share price could reach 1600 by Jul 7 2023. Athira Pharma Stock Forecast. Forecast for 2022 Aug.
The average price target for Athira Pharma Inc. Find the latest Athira Pharma Inc. Stock forecast for tomorrow and next 5 days.
ATHA Earnings Date and Information. Is 348 for 2026 Jul. The Score for ATHA is 52 which is 4 above its historic.
Find the latest Athira Pharma Inc. Athira Pharma stock monthly and weekly forecasts. On average Wall Street analysts predict.
1 day and price target of 330 USD. ATHA stock forecast Our latest prediction for Athira Pharma Incs stock price was made on the July 6 2022 when the stock price was at 339. Is 407 and for 2031 Jul.
Is Athira Pharma Stock Undervalued. According to 12 stock analysts the. ATHA share price prediction for 2022 2023 2024 2025 2026 and 2027.
The average price target is 425 with a high forecast of. Get the latest ATHA stock forecast powered by the most important price indicators. The current Athira Pharma ATHA share price is 297.
ATHA stock quote history news and other vital information to help you with your stock trading and investing. In the short term 2weeks. Get an edge in the market with our Athira Pharma Inc.
The average Athira Pharma stock price prediction forecasts a potential upside of. Is 334 for 2027 Jul. The average Athira Pharma stock price prediction represents a 31010 increase from the current ATHA stock price of 1079 Earnings Forecast for Athira Pharma Stock.
ATHA analyst stock forecast price target and recommendation trends with in-depth analysis from research reports. Athira Pharma Provides Update on Plans for Ongoing LIFT-AD Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimers Patients. A buy signal was issued from a pivot bottom point on Friday September 30 2022 and so far it has risen 606Further rise is indicated until a new top pivot.
Find real-time ATHA - Athira Pharma Inc stock quotes company profile news and forecasts from CNN Business. The reported 065 earnings per share for the quarter beating the. Athira Pharma last announced its earnings data on August 15th 2022.
Atha Stock Price And Chart Nasdaq Atha Tradingview
Bothell Biotech Firm And Activist Investor Feud Over Control Of Alzheimer S Research The Seattle Times
Seattle Biotech Athira Pharma Sets Terms For Ipo Aims To Raise Up To 170m Geekwire
Last Day For Shareholders To Actively Participate In Athira Pharma Inc Atha Class Action Bronstein Gewirtz Grossman Llc Business Wire
76 Biggest Movers From Yesterday Ocean Bio Chem Athira Pharma And More Anebulo Pharmaceuticals Nasdaq Aneb Ads Tec Energy Nasdaq Adse Benzinga
Goldman Sachs 2 Stocks That Could Climb Over 90 Nasdaq
Athira Pharma Inc Atha Stock Price Quote News Stock Analysis
Atha Athira Pharma Stock Price
Price Forecasting Models For Athira Pharma Inc Atha Stock Ta Ton Viet Amazon Com Au Books
Athira Pharma Inc Atha Stock Price Quote News Stock Analysis
Athira Pharma Seeks 160 Million To Advance Alzheimer S Treatment Nasdaq Atha Seeking Alpha
Atha Stock Price Forecast Should You Buy Atha
What Kind Of Shareholders Own Athira Pharma Inc Nasdaq Atha
Atha Athira Pharma Inc Cnnmoney Com
Inmb Stock Forecast Price News Inmune Bio
One Day Remaining For Shareholders To Actively Participate In Athira Pharma Inc Atha Class Action Bronstein Gewirtz Grossman Llc
Athira Pharma Stock Nasdaq Atha Quotes And News Summary Benzinga